Facebook
Twitter
LinkedIn
Forward
Detecting and Addressing Trauma-Related Sequelae in Primary Care
Instructions
Click the REGISTER button to take the posttest.
Click here to return to the PCC CME article.
Overview
Adoption of trauma-informed care practices shows promise for improving patient engagement, treatment adherence, and health outcomes.
Read the whole article at psychiatrist.com/pcc here:
Detecting and Addressing Trauma-Related Sequelae in Primary Care
© Copyright 2021 Physicians Postgraduate Press, Inc.
Target Audience
Primary care clinicians
Learning Objectives
Implement trauma-informed practices
CME Background
Articles are selected for credit designation based on an assessment of the educational needs of CME participants, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. Activities are planned using a process that links identified needs with desired results.
CME Objective
After studying this article, you should be able to:
- Implement trauma-informed practices
Statement of Need and Purpose
Primary care physicians face multiple competing demands during the ambulatory encounter—a situation magnified in practices in which the population may be at high risk for trauma and who concurrently experience other sources of adversity such as socioeconomic vulnerability. Primary care physicians often fail to uncover PTSD diagnoses or develop treatment plans to address posttraumatic stress symptoms for their patients. Education on the association between trauma symptomatology, adverse childhood experiences, and social determinants of health in vulnerable primary care populations is warranted to inform the clinical care of patients with trauma sequelae.
Release, Expiration, and Review Dates
This educational activity was published in June 2021 and is eligible for AMA PRA Category 1 Credit™ through June 30, 2023. The latest review of this material was June 2021.
Disclosure of Off-Label Usage
The authors have determined that, to the best of their knowledge, no investigational information about pharmaceutical agents or device therapies that is outside US Food and Drug Administration–approved labeling has been presented in this article.
Funding/Support
Research reported in this publication was supported in part by the US Health Resources and Services Administration (HRSA), Bureau of Health Professions, Academic Administrative Units Award No. D54HP05259; the Academy of Teaching Scholars, College of Medicine, University of Oklahoma Health Sciences Center; and the Telligen Community Initiative, Healthcare Workforce Development Program.
Role of the Sponsor
The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; or preparation, review, or approval of the manuscript.
Faculty Affiliation
Kim A. Coon, EdD*
Department of Psychiatry, The OU-TU School of Community Medicine, Tulsa, Oklahoma
Julie Miller-Cribbs, MSW, PhD
Anne and Henry Zarrow School of Social Work, University of Oklahoma, Norman, Oklahoma
Frances Wen, PhD
Department of Family and Community Medicine, The OU-TU School of Community Medicine, Tulsa, Oklahoma
Martina Jelley, MD, MSPH, FACP
Department of Internal Medicine, The OU-TU School of Community Medicine, Tulsa, Oklahoma
Ginger Sutton, BA
Department of Family and Community Medicine, The OU-TU School of Community Medicine, Tulsa, Oklahoma
*Corresponding author: Kim A. Coon, EdD, Department of Psychiatry, The OU-TU School of Community Medicine, 4502 East 41st St, Tulsa, OK 74135 ([email protected]).
Financial Disclosure
All individuals in a position to influence the content of this activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. In the past year, Marlene P. Freeman, MD, Editor in Chief of The Journal of Clinical Psychiatry, has received research funding from JayMac and Sage; has been a member of the advisory boards for Otsuka, Alkermes, and Sunovion; has been a member of the Independent Data Safety and Monitoring Committee for Janssen; has been a member of the Steering Committee for Educational Activities for Medscape; and, as a Massachusetts General Hospital (MGH) employee, works with the MGH National Pregnancy Registry, which is sponsored by Teva, Alkermes, Otsuka, Actavis, and Sunovion, and works with the MGH Clinical Trials Network and Institute, which receives research funding from multiple pharmaceutical companies and the National Institute of Mental Health. No member of the CME Institute staff reported any relevant personal financial relationships.
Drs Coon, Miller-Cribbs, Wen, and Jelley and Ms Sutton have no personal affiliations or financial relationships with any commercial interest to disclose relative to the article.
Accreditation Statement
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The CME Institute of Physicians Postgraduate Press, Inc., designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation